Vitamin D and cognitive function
暂无分享,去创建一个
Kerry Jones | David Melzer | D. Melzer | I. Lang | K. Kos | Maya Soni | D. Llewellyn | Kerry Jones | David J Llewellyn | Iain A Lang | Katarina Kos | Maya Soni
[1] Philip W. Landfield,et al. Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons , 2001, The Journal of Neuroscience.
[2] C. Colón-Emeric,et al. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. , 2010, The American journal of geriatric pharmacotherapy.
[3] R. Chandra. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. , 2001, Nutrition.
[4] W. Grant,et al. Epidemiology of disease risks in relation to vitamin D insufficiency. , 2006, Progress in biophysics and molecular biology.
[5] B. Roberts,et al. Malnutrition and feeding difficulty in Taiwanese older with dementia. , 2011, Journal of clinical nursing.
[6] M. Somerville,et al. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. , 1992, Brain research. Molecular brain research.
[7] C. Annweiler,et al. Association of vitamin D deficiency with cognitive impairment in older women , 2010, Neurology.
[8] D. Melzer,et al. Vitamin D and risk of cognitive decline in elderly persons. , 2010, Archives of internal medicine.
[9] L. Buée,et al. Neurotrophic factors in Alzheimer’s disease: role of axonal transport , 2008, Genes, brain, and behavior.
[10] J. Cauley,et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men , 2010, Neurology.
[11] Graham D Carter,et al. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. , 2011, Current drug targets.
[12] D. Eyles,et al. Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases , 2009, Psychoneuroendocrinology.
[13] J. Iwamoto,et al. RETRACTED ARTICLE: Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer’s disease , 2009, Aging clinical and experimental research.
[14] R. Cohen,et al. Do vitamin D supplements improve the physical capabilities of elderly hospital patients? , 1985, Age and ageing.
[15] Steven A. Smith,et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. , 2005, Journal of chemical neuroanatomy.
[16] W. März,et al. Low Vitamin D Levels Predict Stroke in Patients Referred to Coronary Angiography , 2008, Stroke.
[17] N. Porter,et al. Chronic 1α,25-(OH)2vitamin D3 treatment reduces Ca2+-mediated hippocampal biomarkers of aging , 2006 .
[18] Z. Walker,et al. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine , 2009, International Psychogeriatrics.
[19] 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services , 2010, Neurology.
[20] C. Mathieu,et al. Vitamin D and diabetes , 2005, Diabetologia.
[21] H. Brenner,et al. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. , 2010, Preventive medicine.
[22] K. Abel,et al. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. , 2009, Journal of Alzheimer's disease : JAD.
[23] Stroke risk profiles. , 2009, Stroke.
[24] N. Porter,et al. Chronic 1alpha,25-(OH)2 vitamin D3 treatment reduces Ca2+ -mediated hippocampal biomarkers of aging. , 2006, Cell calcium.
[25] M. Dewey,et al. Neurosis and mortality in persons aged 65 and over living in the community: a systematic review of the literature , 2004, International journal of geriatric psychiatry.
[26] J. McGrath,et al. Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.
[27] Karen W Phinney,et al. Development of a standard reference material for vitamin D in serum. , 2008, The American journal of clinical nutrition.
[28] I. Lang,et al. Vitamin D, Cognitive Dysfunction and Dementia in Older Adults , 2011, CNS drugs.
[29] P. Landfield,et al. Early and Simultaneous Emergence of Multiple Hippocampal Biomarkers of Aging Is Mediated by Ca2+-Induced Ca2+ Release , 2006, The Journal of Neuroscience.
[30] Yvette I Sheline,et al. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[31] E. Michos,et al. Vitamin D in atherosclerosis, vascular disease, and endothelial function. , 2011, Current drug targets.
[32] L. Lue,et al. Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease , 2010, Molecular Neurobiology.
[33] H. Brenner,et al. Meta-analysis: Serum vitamin D and colorectal adenoma risk. , 2011, Preventive medicine.
[34] H. Gronemeyer,et al. Cross‐talk of vitamin D and glucocorticoids in hippocampal cells , 2006, Journal of neurochemistry.
[35] S. Yılmazer,et al. A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons. , 2011, Journal of Alzheimer's disease : JAD.
[36] W. Grant. Does vitamin D reduce the risk of dementia? , 2009, Journal of Alzheimer's disease : JAD.
[37] C. Rbsner. Do vitamin D supplements improve the physical capabilities of elderly hospital patients ? , 2005 .
[38] I. Lang,et al. Serum 25-Hydroxyvitamin D Concentration and Cognitive Impairment , 2009, Journal of geriatric psychiatry and neurology.
[39] T. Foster,et al. Calcium Dysregulation in the Aging Brain , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[40] D. Melzer,et al. Vitamin D and cognitive impairment in the elderly U.S. population. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.
[41] M. Dewey,et al. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature , 2001, International journal of geriatric psychiatry.
[42] E. Warburton,et al. Reduced Vitamin D in Acute Stroke , 2006, Stroke.
[43] P. Raina,et al. Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline , 2008, Annals of Internal Medicine.
[44] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[45] C. Annweiler,et al. [Vitamin D in the elderly: 5 points to remember]. , 2011, Geriatrie et psychologie neuropsychiatrie du vieillissement.
[46] B. Bao,et al. Protective role of 1α, 25‐dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells , 2008, International journal of cancer.
[47] D. Houston,et al. Correlates and Prevalence of Insufficient 25‐Hydroxyvitamin D Status in Black and White Older Adults: The Health, Aging and Body Composition Study , 2011, Journal of the American Geriatrics Society.
[48] D. Le Gall,et al. 25-HYDROXYVITAMIN D, DEMENTIA, AND CEREBROVASCULAR PATHOLOGY IN ELDERS RECEIVING HOME SERVICES , 2010, Neurology.
[49] M. Folstein,et al. Vitamin D is associated with cognitive function in elders receiving home health services. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.
[50] Elizabeth K. Pogge. Vitamin D and Alzheimer's disease: is there a link? , 2010, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.